A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

Part of paid clinical trials in Cypress, California.

Sponsor
AbbVie
Study ID
NCT07219030
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Healthy Volunteer

Eligibility Criteria

Sex
ALL
Age
65 Years - 85 Years
Healthy Volunteers
Accepted

Interventions

  • Emraclidine — DRUG
    Oral tablets
  • Placebo — DRUG
    Oral tablets

Study Details

This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerability.

Key Dates

Start date
Oct 8, 2025
Status verified
May 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Emraclidine or Placebo- Group 1
    Participants will receive oral doses of emraclidine or placebo for 10 days or 17 days
  • Experimental: Emraclidine or Placebo- Group 2
    Participants will receive oral doses of emraclidine or placebo for 10 days or 17 days
  • Experimental: Emraclidine or Placebo- Group 3
    Participants will receive oral doses of emraclidine or placebo for 10 days or 17 days.
  • Experimental: Emraclidine or Placebo- Group 4
    Participants will receive oral doses of emraclidine or placebo for 10 days or 17 days.
  • Experimental: Emraclidine or Placebo- Group 5
    Participants will receive oral doses of emraclidine or placebo for 10 days or 17 days.

Primary Outcome Measure

Number of Participants Experiencing Adverse Events [ Time Frame: Up to approximately 50 days ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Altasciences Clinical Los Angeles /ID# 276854CypressCalifornia90630-
K2 Medical Research, LLC /ID# 276636MaitlandFlorida32751-
Clinical Pharmacology Of Miami /ID# 276856MiamiFlorida33172
Site Coordinator
786-493-9466
Acpru /Id# 276996GrayslakeIllinois60030
Site Coordinator
847-935-4400

Find similar trials in Cypress, CA

By research site
Altasciences Clinical Los Angeles· Cypress, CAK2 Medical Research, LLC· Maitland, FLClinical Pharmacology Of Miami· Miami, FLAcpru· Grayslake, IL

Related Studies